利索-全球专利检索

  1. 登录
  2. 注册
发明申请
US20060046958A1 Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia 失效
包含前列腺素相关化合物和三叶因子家族肽用于治疗青光眼与降低充血的组合物和方法

  • 专利标题： Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
  • 专利标题（中）： 包含前列腺素相关化合物和三叶因子家族肽用于治疗青光眼与降低充血的组合物和方法
  • 申请号： US10521367
    申请日： 2004-08-25
  • 公开(公告)号： US20060046958A1
    公开(公告)日： 2006-03-02
  • 发明人: Peter Bakhit , Richard Graham , Orest Olejnik
  • 申请人： Peter Bakhit , Richard Graham , Orest Olejnik
  • 国际申请： PCT/US04/27777 WO 20040825
  • 主分类号： A61K38/17
  • IPC分类号： A61K38/17 ;  A61K31/715 ;  A61K31/557
Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
摘要：
Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
摘要（中）：

本文公开了与前列腺素相关化合物和三叶因子家族肽相关的组合物，方法和药物产品。 特别感兴趣的是用于治疗青光眼的组合物和方法，其中发生充血发生。

公开/授权文献
信息查询
Global Dossier Espacenet
0/0